EXCLUSIVE: Prism Healthcare announces major new investor to help it realise growth objectives
Yorkshire-based medical equipment provider Prism Healthcare has announced that Charme Capital Partners (London) will be its new majority investor.
Charme will be supported by the firm’s existing investor Limerston Capital, a London-based private equity firm.
Under Limerston’s ownership and guidance, Prism Healthcare has consolidated its position as a market leader in Homecare and Long Term Care services.
Over the last three years the business has doubled in size, acquired additional services and products to become the most comprehensive provider in the country by helping our customers make caring easier for their clients.
Charme’s investment will support the Group’s expansion plans through the continued development of its high-quality offering, investments in IT and UK manufacturing to enable the very best client care. Charme will also support the Group’s growth via acquisition, both in the UK and internationally.
Paul Morton, CEO of Prism Healthcare, commented: “We are thrilled to welcome Charme as a new investor in Prism Healthcare to support the Group’s continued development. We are confident that Charme is the right partner, with the right skills and experience, to help us realise our ambitious growth objectives.
“We are excited to embark on a new chapter for Prism Healthcare, whilst continuing to support our customers and their clients in homecare, long term care and the paediatric market by making care easier.”
Headquartered in Wakefield, Yorkshire, Prism Healthcare has a diverse portfolio of UK manufactured equipment, including safe patient handling, bathing, accessibility and pressure area care products.
The firm employs over 650 people and operates from across nine UK locations, with a network of international distributors. In January 2021, Prism Healthcare added a new company to its stable with the purchase of Repose Furniture.
Its products claim to provide healthcare professionals with affordable, clinically effective solutions to help disabled and mobility disadvantaged people remain mobile and active in their own homes, in long term care facilities or in acute care environments.
Charme Capital Partners is based in London, Milan and Madrid, and is the manager of the Charme Funds. The firm was founded in 2003 and is backed by a unique combination of institutional LPs and prominent global industrialists.
Since inception, the Charme Funds have raised over €1.8 billion and invested with a pan-European approach in companies with strong growth and internationalisation prospects.https://thiis.co.uk/exclusive-prism-healthcare-announces-major-new-investor-to-help-it-realise-growth-objectives/https://thiis.co.uk/wp-content/uploads/2022/03/LDC-exits-Prism-Medical-UK-18-Dec_944x755.jpghttps://thiis.co.uk/wp-content/uploads/2022/03/LDC-exits-Prism-Medical-UK-18-Dec_944x755-150x150.jpgNewsroomSupplier NewsTrade NewsCharme Capital Partners,equipment,equity,investor,Limerston,medical,Mobility,Prism Healthcare,YorkshireYorkshire-based medical equipment provider Prism Healthcare has announced that Charme Capital Partners (London) will be its new majority investor. Charme will be supported by the firm's existing investor Limerston Capital, a London-based private equity firm. Under Limerston’s ownership and guidance, Prism Healthcare has consolidated its position as a market leader in...Liane McIvorLiane McIvorliane@thiis.co.ukAdministratorTHIIS Magazine